$75.15
-0.04-0.05%
Last update: 2:50 PM
15 minutes delayed
Comments
Loading...
MetLife
METNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
MetLife (NYSE:MET) Stock, Analyst Ratings, Price Targets, Forecasts
MetLife Inc has a consensus price target of $80.5 based on the ratings of 17 analysts. The high is $89 issued by Citigroup on July 23, 2024. The low is $71 issued by Barclays on November 17, 2023. The 3 most-recent analyst ratings were released by Citigroup, Jefferies, and Morgan Stanley on July 23, 2024, July 18, 2024, and July 10, 2024, respectively. With an average price target of $86 between Citigroup, Jefferies, and Morgan Stanley, there's an implied 14.44% upside for MetLife Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Jefferies
Morgan Stanley
Keefe, Bruyette & Woods
JP Morgan
1calculated from analyst ratings
Analyst Ratings for MetLife
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/23/2024 | Buy Now | 18.43% | Citigroup | Michael Ward | $83 → $89 | Maintains | Buy | Get Alert |
| 07/18/2024 | Buy Now | 14.44% | Jefferies | Suneet Kamath | $83 → $86 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 10.45% | Morgan Stanley | Nigel Dally | $82 → $83 | Maintains | Overweight | Get Alert |
| 07/08/2024 | Buy Now | 13.11% | Keefe, Bruyette & Woods | Ryan Krueger | $86 → $85 | Maintains | Outperform | Get Alert |
| 07/02/2024 | Buy Now | 14.44% | JP Morgan | Jimmy Bhullar | $81 → $86 | Maintains | Overweight | Get Alert |
| 06/28/2024 | Buy Now | 10.45% | Jefferies | Suneet Kamath | $88 → $83 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | 6.45% | Argus Research | Kevin Heal | $77 → $80 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 13.11% | Wells Fargo | Elyse Greenspan | $86 → $85 | Maintains | Overweight | Get Alert |
| 05/07/2024 | Buy Now | 14.44% | Keefe, Bruyette & Woods | Ryan Krueger | $87 → $86 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | 9.12% | Piper Sandler | John Barnidge | $85 → $82 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | 9.12% | Morgan Stanley | Nigel Dally | $80 → $82 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 14.44% | Wells Fargo | Elyse Greenspan | $83 → $86 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 15.77% | Keefe, Bruyette & Woods | Ryan Krueger | $82 → $87 | Maintains | Outperform | Get Alert |
| 04/05/2024 | Buy Now | 13.11% | Piper Sandler | John Barnidge | $74 → $85 | Maintains | Overweight | Get Alert |
| 02/06/2024 | Buy Now | 10.45% | Wells Fargo | Elyse Greenspan | $85 → $83 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | 9.12% | UBS | Brian Meredith | $87 → $82 | Maintains | Buy | Get Alert |
| 01/10/2024 | Buy Now | 15.77% | UBS | Brian Meredith | $84 → $87 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | 6.45% | Goldman Sachs | Alex Scott | $70 → $80 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | 6.45% | Goldman Sachs | Alex Scott | → $80 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2023 | Buy Now | 2.46% | Keefe, Bruyette & Woods | Ryan Krueger | $79 → $77 | Maintains | Outperform | Get Alert |
| 11/17/2023 | Buy Now | -5.52% | Barclays | Tracy Benguigui | → $71 | Reinstates | → Overweight | Get Alert |
| 11/02/2023 | Buy Now | 6.45% | Morgan Stanley | Nigel Dally | $79 → $80 | Maintains | Overweight | Get Alert |
| 10/06/2023 | Buy Now | 9.12% | JP Morgan | Jimmy Bhullar | $85 → $82 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | -4.19% | Jefferies | Suneet Kamath | $58 → $72 | Upgrade | Hold → Buy | Get Alert |
| 08/18/2023 | Buy Now | 5.12% | Morgan Stanley | Nigel Dally | $78 → $79 | Maintains | Overweight | Get Alert |
| 08/15/2023 | Buy Now | 10.45% | Wells Fargo | Elyse Greenspan | $82 → $83 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | 2.46% | Argus Research | Kevin Heal | $70 → $77 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | 7.78% | Citigroup | Michael Ward | $76 → $81 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -1.53% | RBC Capital | Mark Dwelle | $70 → $74 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 3.79% | Morgan Stanley | Nigel Dally | $78 → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 9.12% | Wells Fargo | Elyse Greenspan | $75 → $82 | Maintains | Overweight | Get Alert |
| 06/15/2023 | Buy Now | 1.13% | Citigroup | Michael Ward | $85 → $76 | Maintains | Buy | Get Alert |
| 06/09/2023 | Buy Now | 6.45% | Keefe, Bruyette & Woods | Ryan Krueger | $86 → $80 | Reiterates | → Outperform | Get Alert |
| 06/02/2023 | Buy Now | 3.79% | Morgan Stanley | Nigel Dally | $80 → $78 | Maintains | Overweight | Get Alert |
| 05/26/2023 | Buy Now | -13.51% | RBC Capital | Mark Dwelle | $68 → $65 | Maintains | Outperform | Get Alert |
| 05/26/2023 | Buy Now | -0.2% | Wells Fargo | Elyse Greenspan | $72 → $75 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | -9.51% | RBC Capital | Mark Dwelle | $76 → $68 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 1.13% | RBC Capital | Mark Dwelle | $83 → $76 | Maintains | Outperform | Get Alert |
| 04/12/2023 | Buy Now | 5.12% | Barclays | Tracy Benguigui | $83 → $79 | Maintains | Overweight | Get Alert |
| 04/12/2023 | Buy Now | 6.45% | Morgan Stanley | Nigel Dally | $90 → $80 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -1.53% | Piper Sandler | John Barnidge | $82 → $74 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -4.19% | Wells Fargo | Elyse Greenspan | $84 → $72 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | -13.51% | Goldman Sachs | Alex Scott | $79 → $65 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 19.76% | Morgan Stanley | Nigel Dally | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | 10.45% | Wells Fargo | Elyse Greenspan | $81 → $83 | Maintains | Overweight | Get Alert |
| 01/10/2023 | Buy Now | 17.1% | Morgan Stanley | Nigel Dally | $87 → $88 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | 3.79% | Goldman Sachs | Alex Scott | $80 → $78 | Downgrade | Buy → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 6.45% | JP Morgan | Jimmy Bhullar | $77 → $80 | Maintains | Overweight | Get Alert |
| 12/09/2022 | Buy Now | 9.12% | Jefferies | Suneet Kamath | $86 → $82 | Downgrade | Buy → Hold | Get Alert |
| 11/17/2022 | Buy Now | 15.77% | Morgan Stanley | Nigel Dally | $85 → $87 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | 2.46% | JP Morgan | Jimmy Bhullar | $74 → $77 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | 13.11% | Morgan Stanley | Nigel Dally | $83 → $85 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | -1.53% | Wells Fargo | Elyse Greenspan | $75 → $74 | Maintains | Overweight | Get Alert |
| 09/22/2022 | Buy Now | — | Raymond James | Wilma Burdis | — | Initiates | → Market Perform | Get Alert |
| 08/22/2022 | Buy Now | 2.46% | Credit Suisse | Andrew Kligerman | $68 → $77 | Maintains | Outperform | Get Alert |
| 08/17/2022 | Buy Now | 10.45% | Morgan Stanley | Nigel Dally | $79 → $83 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | 5.12% | Morgan Stanley | Nigel Dally | $78 → $79 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | -0.2% | Barclays | Tracy Benguigui | $79 → $75 | Maintains | Overweight | Get Alert |
| 07/06/2022 | Buy Now | 6.45% | Evercore ISI Group | Thomas Gallagher | $81 → $80 | Maintains | Outperform | Get Alert |
| 07/06/2022 | Buy Now | 3.79% | Morgan Stanley | Nigel Dally | $80 → $78 | Maintains | Overweight | Get Alert |
| 06/23/2022 | Buy Now | -1.53% | Wolfe Research | Michael Zaremski | $70 → $74 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/24/2022 | Buy Now | 2.46% | Citigroup | Michael Ward | → $77 | Initiates | → Buy | Get Alert |
| 05/05/2022 | Buy Now | 6.45% | Morgan Stanley | Nigel Dally | $79 → $80 | Maintains | Overweight | Get Alert |
| 04/12/2022 | Buy Now | 5.12% | Barclays | Tracy Benguigui | $76 → $79 | Maintains | Overweight | Get Alert |
| 04/06/2022 | Buy Now | 6.45% | Piper Sandler | John Barnidge | $77 → $80 | Maintains | Overweight | Get Alert |
| 02/22/2022 | Buy Now | 5.12% | Morgan Stanley | Nigel Dally | $76 → $79 | Maintains | Overweight | Get Alert |
| 01/26/2022 | Buy Now | -1.53% | Jefferies | Suneet Kamath | → $74 | Initiates | → Buy | Get Alert |
| 01/21/2022 | Buy Now | -6.85% | Wolfe Research | Michael Zaremski | → $70 | Initiates | → Peer Perform | Get Alert |
| 01/11/2022 | Buy Now | -0.2% | Barclays | Tracy Benguigui | $72 → $75 | Maintains | Overweight | Get Alert |
| 01/07/2022 | Buy Now | 1.13% | Morgan Stanley | Nigel Dally | $75 → $76 | Maintains | Overweight | Get Alert |
| 01/05/2022 | Buy Now | -1.53% | Evercore ISI Group | Thomas Gallagher | $67 → $74 | Upgrade | In-Line → Outperform | Get Alert |
| 01/04/2022 | Buy Now | -1.53% | Wells Fargo | Elyse Greenspan | $75 → $74 | Maintains | Overweight | Get Alert |
| 12/03/2021 | Buy Now | 2.46% | Goldman Sachs | Alex Scott | — | Initiates | → Buy | Get Alert |
| 10/14/2021 | Buy Now | -0.2% | Morgan Stanley | Nigel Dally | — | Maintains | Overweight | Get Alert |
| 10/12/2021 | Buy Now | -4.19% | Barclays | Tracy Benguigui | — | Maintains | Overweight | Get Alert |
| 08/05/2021 | Buy Now | -1.53% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for MetLife (MET) stock?
The latest price target for MetLife (NYSE:MET) was reported by Citigroup on July 23, 2024. The analyst firm set a price target for $89.00 expecting MET to rise to within 12 months (a possible 18.43% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MetLife (MET)?
The latest analyst rating for MetLife (NYSE:MET) was provided by Citigroup, and MetLife maintained their buy rating.
When was the last upgrade for MetLife (MET)?
The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.
When was the last downgrade for MetLife (MET)?
The last downgrade for MetLife Inc happened on January 9, 2023 when Goldman Sachs changed their price target from $80 to $78 for MetLife Inc.
When is the next analyst rating going to be posted or updated for MetLife (MET)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
Is the Analyst Rating MetLife (MET) correct?
While ratings are subjective and will change, the latest MetLife (MET) rating was a maintained with a price target of $83.00 to $89.00. The current price MetLife (MET) is trading at is $75.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.